Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report)’s stock price rose 2.7% on Wednesday . The company traded as high as $290.63 and last traded at $290.30. Approximately 1,872,102 shares changed hands during trading, a decline of 65% from the average session volume of 5,399,010 shares. The stock had previously closed at $282.65.
Analysts Set New Price Targets
Several research analysts recently commented on ALAB shares. Evercore reaffirmed an “outperform” rating and issued a $297.00 target price on shares of Astera Labs in a research note on Tuesday, May 19th. Rothschild & Co Redburn began coverage on shares of Astera Labs in a research report on Friday, May 1st. They set a “neutral” rating and a $153.00 price target for the company. Zacks Research raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. Morgan Stanley boosted their price objective on shares of Astera Labs to $335.00 and gave the company an “overweight” rating in a research report on Monday, August 3rd. Finally, Royal Bank Of Canada upped their price objective on shares of Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat.com, Astera Labs has a consensus rating of “Moderate Buy” and an average price target of $333.00.
Check Out Our Latest Stock Analysis on ALAB
Astera Labs Price Performance
Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm’s revenue was up 104.5% on a year-over-year basis. During the same quarter last year, the firm posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current year.
Insider Transactions at Astera Labs
In related news, Director Stefan A. Dyckerhoff sold 8,994 shares of the business’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $311.83, for a total transaction of $2,804,599.02. Following the transaction, the director owned 3,970 shares in the company, valued at $1,237,965.10. The trade was a 69.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. The trade was a 6.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders sold 419,244 shares of company stock worth $163,135,169. 10.40% of the stock is owned by corporate insiders.
Institutional Trading of Astera Labs
Several institutional investors and hedge funds have recently bought and sold shares of the stock. California State Teachers Retirement System raised its position in shares of Astera Labs by 49,273.2% in the 2nd quarter. California State Teachers Retirement System now owns 100,158,544 shares of the company’s stock worth $48,378,580,000 after acquiring an additional 99,955,684 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Astera Labs by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after purchasing an additional 84,365 shares in the last quarter. BlackRock Inc. bought a new stake in shares of Astera Labs during the second quarter valued at approximately $6,609,581,000. Atreides Management LP grew its stake in Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after purchasing an additional 1,754,593 shares during the period. Finally, State Street Corp raised its holdings in Astera Labs by 32.5% in the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after purchasing an additional 760,358 shares in the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Further Reading
- Five stocks we like better than Astera Labs
- Could Falling Yields Make REIT Stocks Worth a Second Look?
- CrowdStrike’s “Mythos Moment” Tests the Bigger AI Security Trade
- 3 Stocks Facing New Pressure From Section 338 Tariffs on Canadian Goods
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
